KR100830270B1 - 식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 - Google Patents
식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 Download PDFInfo
- Publication number
- KR100830270B1 KR100830270B1 KR1020060059174A KR20060059174A KR100830270B1 KR 100830270 B1 KR100830270 B1 KR 100830270B1 KR 1020060059174 A KR1020060059174 A KR 1020060059174A KR 20060059174 A KR20060059174 A KR 20060059174A KR 100830270 B1 KR100830270 B1 KR 100830270B1
- Authority
- KR
- South Korea
- Prior art keywords
- enteric
- glucosamine
- tablet
- shellac
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 7
- 238000009505 enteric coating Methods 0.000 title abstract description 19
- 239000002702 enteric coating Substances 0.000 title abstract description 19
- 239000003826 tablet Substances 0.000 title description 46
- 239000002662 enteric coated tablet Substances 0.000 title description 2
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 30
- 229920001800 Shellac Polymers 0.000 claims abstract description 27
- 239000004208 shellac Substances 0.000 claims abstract description 27
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims abstract description 27
- 235000013874 shellac Nutrition 0.000 claims abstract description 27
- 229940113147 shellac Drugs 0.000 claims abstract description 27
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 21
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 17
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 16
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 16
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 34
- 229960002442 glucosamine Drugs 0.000 claims description 34
- MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 19
- 235000014655 lactic acid Nutrition 0.000 claims description 17
- 239000004310 lactic acid Substances 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000008199 coating composition Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 235000013402 health food Nutrition 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 7
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 150000002301 glucosamine derivatives Chemical class 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 235000010980 cellulose Nutrition 0.000 claims description 5
- 235000012239 silicon dioxide Nutrition 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 241001072261 Musculista senhousia Species 0.000 claims description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 235000008504 concentrate Nutrition 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 12
- 210000000936 intestine Anatomy 0.000 abstract description 12
- 230000000052 comparative effect Effects 0.000 description 32
- 238000002360 preparation method Methods 0.000 description 10
- 229920002494 Zein Polymers 0.000 description 9
- 239000005019 zein Substances 0.000 description 9
- 229940093612 zein Drugs 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000011247 coating layer Substances 0.000 description 4
- 229960002849 glucosamine sulfate Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 210000005067 joint tissue Anatomy 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229920001688 coating polymer Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/22—Coating agent
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5108—Cellulose
- A23V2250/51086—Hydroxyalkyl cellulose
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
시험항목 시험대상 | 붕해 여부 | 적합 여부 | |
pH 1.2(2시간) | pH 6.8(1시간) | ||
실시예 1 | 붕해안됨 | 붕해됨 | 적합 |
비교예 1 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 2 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 3 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 4 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 5 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 6 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 7 | 붕해됨 | - | 부적합 |
비교예 8 | 붕해됨 | - | 부적합 |
비교예 9 | 붕해됨 | - | 부적합 |
비교예 10 | 붕해됨 | - | 부적합 |
비교예 11 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 12 | 붕해안됨 | 붕해안됨 | 부적합 |
비교예 13 | 붕해안됨 | 붕해안됨 | 부적합 |
Claims (10)
- 삭제
- 삭제
- 건강보조제와 건강보조제에 대하여 쉘락 0.5 내지 5 중량부, 하이드록시프로필메틸셀룰로오스(HPMC) 0.1 내지 1 중량부를 포함하는 코팅 조성물로 코팅된 장용성 건강식품 조성물.
- 제3항에 있어서, 건강 보조제는 글루코사민, 글루코사민의 유도체, 유산균 및 β-갈락토시다제 또는 이들의 혼합물 중에서 선택되는 조성물.
- 제 4 항에 있어서, 글루코사민 또는 글루코사민 유도체는, 글루코사민의 의 약제학적으로 허용되는 모든 염 또는 글루코사민 유도체의 약제학적으로 허용되는 염을 포함하는 것인 조성물.
- 건강 보조제로 나정을 제조하는 단계; 및건강보조제 나정에 대해 0.5 내지 5 중량부의 쉘락 및 0.1 내지 1 중량부의 하이드록시프로필메틸셀룰로오스(HPMC)를 포함하는 코팅조성물로 상기 나정을 코팅하는 단계를 포함하는 장용성 건강식품 정제의 제조 방법,
- 제 6 항에 있어서, 나정을 제조하기 전에 건강보조제와 부형제를 혼합하는 단계를 포함하는 장용성 건강식품 정제의 제조방법.
- 제7항에 있어서, 상기 부형제는 미정질 셀룰로즈, 이산화 규소, 창출농축액, 우슬농축액, 맥아농축액, 덱스트린, 녹색홍합분말, 결정셀룰로오스, 이산화규소 및 스테아린산마그네슘으로부터 선택되는 것인 방법.
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060059174A KR100830270B1 (ko) | 2006-06-29 | 2006-06-29 | 식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060059174A KR100830270B1 (ko) | 2006-06-29 | 2006-06-29 | 식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080001079A KR20080001079A (ko) | 2008-01-03 |
KR100830270B1 true KR100830270B1 (ko) | 2008-05-16 |
Family
ID=39213155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060059174A KR100830270B1 (ko) | 2006-06-29 | 2006-06-29 | 식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100830270B1 (ko) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990029838A (ko) * | 1997-09-19 | 1999-04-26 | 테츠로 이케카와 | 버섯 또는 그 추출물을 함유하는 조성물 |
WO2000064279A1 (en) | 1999-04-23 | 2000-11-02 | E Excel International Inc. | Cactus fruit health products |
KR20030064799A (ko) * | 2000-11-30 | 2003-08-02 | 닛신 오일리오 가부시키가이샤 | 미백용 음식물 및 경구 미백제 |
KR20030087024A (ko) * | 2001-04-11 | 2003-11-12 | 비오 세래 라보라뚜와르 | 지방 고정 특성을 갖는 선인장-기초 제제 및 그 제조방법 |
KR20030090397A (ko) * | 2002-05-23 | 2003-11-28 | 알앤엘생명과학주식회사 | 손바닥 선인장 분말의 방출제어형 코팅과립 및 이의제조방법 |
-
2006
- 2006-06-29 KR KR1020060059174A patent/KR100830270B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990029838A (ko) * | 1997-09-19 | 1999-04-26 | 테츠로 이케카와 | 버섯 또는 그 추출물을 함유하는 조성물 |
WO2000064279A1 (en) | 1999-04-23 | 2000-11-02 | E Excel International Inc. | Cactus fruit health products |
KR20030064799A (ko) * | 2000-11-30 | 2003-08-02 | 닛신 오일리오 가부시키가이샤 | 미백용 음식물 및 경구 미백제 |
KR20030087024A (ko) * | 2001-04-11 | 2003-11-12 | 비오 세래 라보라뚜와르 | 지방 고정 특성을 갖는 선인장-기초 제제 및 그 제조방법 |
KR20030090397A (ko) * | 2002-05-23 | 2003-11-28 | 알앤엘생명과학주식회사 | 손바닥 선인장 분말의 방출제어형 코팅과립 및 이의제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20080001079A (ko) | 2008-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU759388B2 (en) | Pharmaceutical compositions containing lipase inhibitors and chitosan | |
US6589555B2 (en) | Effervescent vitaceutical compositions and related methods | |
KR100204115B1 (ko) | 시사프라이드의 즉시 방출형 피에이치-비의존성 고형 제제 | |
CN104161752B (zh) | 一种维格列汀组合物 | |
KR20030074625A (ko) | 삶의 질을 개선하는 의약 및 식품 및 그 제조방법 | |
JP2004521955A (ja) | 新規置換ベンズイミダゾール製剤およびその使用方法 | |
AU2008245597A1 (en) | Solid dosage forms | |
CN101184482A (zh) | 抑制胃酸分泌的组合物和方法 | |
EP1481676B1 (en) | Phytoestrogens and probiotic for women's health | |
NZ564002A (en) | Diclofenac formulations and methods of use | |
EP1790333A1 (en) | Gastroresistant tablet comprising a butyric acid compound | |
CN100379416C (zh) | 稳定的口服固体药物组合物 | |
US20070099843A1 (en) | Nutritional supplement for the enhancement of the health of the liver | |
JP2022184994A (ja) | ブルルリパーゼを含有する口腔内分散性錠剤、ブルルリパーゼを含む液体医薬組成物を調製する方法および口腔内分散性錠剤を生産するプロセス | |
US6447807B1 (en) | Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery | |
EP3193826A1 (en) | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population | |
JP3393560B2 (ja) | 水溶性キトサンを含有するカルシウム吸収促進性組成物およびカルシウム吸収促進用添加剤 | |
TWI469785B (zh) | 用於治療代謝性疾病之膳食纖維組成物 | |
CN109044988A (zh) | 一种盐酸二甲双胍药物组合物及其制备方法和应用 | |
KR100830270B1 (ko) | 식품용 장용피 조성물 및 이를 이용한 장용성 정제 및 그의제조방법 | |
WO2018185669A1 (en) | Effervescent compositions comprising saxagliptin or salt thereof | |
KR20180091572A (ko) | 경구투여용 대장하제조성물 | |
EP3357492B1 (en) | Multilayer tablet for administration of magnesium | |
JP2011088939A (ja) | 内服製剤 | |
CZ2005171A3 (cs) | Farmaceutický prípravek obsahující metformin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 12 |